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Cyclodextrin Mediated Enhancement of Riboflavin 
Solubility and Corneal Permeability  
Peter W. J. Morrison, Che J. Connon, Vitaliy V. Khutoryanskiy* 
School of Pharmacy, University of Reading, Whiteknights, PO Box 224, Reading, RG6 6AD, 
United Kingdom. 
Abstract: Cyclodextrins are water-soluble cyclic oligosaccharides consisting of six, seven and 
eight -(1,4)-linked glucopyranose subunits. This study reports the use of different cyclodextrins 
in eye drop formulations to improve the aqueous solubility and corneal permeability of 
riboflavin. Riboflavin is a poorly water-soluble drug, whose solubility is up to ~0.08 mg mL-1 in 
deionized water. It is used as a drug topically administered to the eye to mediate UV-induced 
corneal cross-linking in the treatment of keratoconus.  Aqueous solutions of ȕ-cyclodextrin (10-
30 mg mL-1) can enhance the solubility of riboflavin up to 0.12 – 0.19 mg mL-1, whereas the 
higher concentration of α-cyclodextrin (100 mg mL-1) achieved a lower level of enhancement of 
0.11 mg mL-1. The other oligosaccharides were found to be inefficient for this purpose. In vitro 
diffusion experiments performed with fresh and cryopreserved bovine cornea have demonstrated 
that ȕ-cyclodextrin enhances riboflavin permeability. The mechanism of this enhancement was 
examined through microscopic histological analysis of the cornea and is discussed in this paper. 
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Introduction 
     Despite easy accessibility of the eye for drug administration, ophthalmic delivery is a very 
challenging area of pharmaceutics; there is the issue of poor permeability due to several ocular 
barriers. Drug retention is impeded by blinking, tear reflex and nasolacrimal drainage.1 Typically 
less than 5% of the topically applied drug penetrates the cornea and reaches intraocular tissues, 
while a major fraction of the instilled dose is often absorbed systemically via the conjunctiva and 
nasolacrimal duct.2 The cornea comprises of five layers, starting from the outermost epithelium, 
Bowman’s membrane, stroma, Descemet’s membrane and endothelium. The epithelium is a 50-
100 m lipophilic layer that contributes around 90% resistance to hydrophilic drugs and 10 % to 
hydrophobic drugs.1,2 Immediately underneath the epithelium is the Bowman’s membrane, a thin 
homogenous layer forming a transition towards the stroma, and it is not considered to be a 
barrier to drugs diffusion. The stroma forms the main section at around 90% of the total corneal 
thickness. It has a hydrophilic gel structure comprised of collagen, other proteins and 
mucopolysaccharides. The stroma may act as the main barrier to very lipophilic drugs. 
Descemet’s membrane is a tough, homogenous band supporting the endothelium, a single layer 
of cells important in keeping the hydration of the stroma constant.1,2  Mammalian eyes typically 
share many of these features and are often used as models representing human eyes.3,4 Bovine 
eyes are established models for drug studies and were used in this work.5 Figure 1 shows a 
micrograph of bovine cornea cross-section highlighting its multilayered structure. 
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Figure 1.   Micrograph of bovine cornea cross-section showing the multilayered structure.  Scale 
bar = 100 µm. 
 
Keratoconus is a degenerative disorder of the eye affecting ~1 in 2000 of the population. This 
debilitating condition results in the cornea becoming more conical leading to serious vision 
distortion. Around 20% of sufferers ultimately require corneal transplantation (penetrating 
keratoplasty).6 In 2003 Wollensak et al published details of a novel treatment for keratoconus 
employing riboflavin as a photosensitive compound to initiate ultraviolet induced collagen cross-
linking in the diseased cornea. The procedure developed by Wollensak relies on physical 
removal of the epithelium to allow riboflavin to enter the corneal stroma.7 Although it is a fully 
established and widely used clinical method to facilitate the riboflavin-mediated corneal cross-
linking, it is an invasive technique that has to be performed under local anesthesia. There is a 
clear need to develop novel formulations that could potentially enhance the penetration of 
riboflavin into the cornea without recourse to surgical removal of the epithelium. 
In the present work we investigated the effects of various cyclodextrins on riboflavin solubility 
and permeability through bovine cornea. We also explored corneal integrity after exposure to 
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cyclodextrin solutions and established that they are able to extract lipids from epithelial 
membranes.  Further work also investigated differences in drug permeability between fresh and 
cryopreserved ocular tissue. 
 
Materials and Methods 
Materials.  Riboflavin, ȕ-cyclodextrin, sodium hexane-1-sulfonate monohydrate and glacial 
acetic acid were purchased from Sigma-Aldrich (Gillingham, UK).  α-cyclodextrin, Ȗ-
cyclodextrin, hydroxypropyl-ȕ-cyclodextrin and cholesterol were obtained from TCI Ltd 
(Oxford, UK).  Sodium chloride, potassium chloride, sodium phosphate, potassium dihydrogen 
phosphate, sodium hydroxide, Minisart syringe filters (0.2 ȝm), optimal cutting temperature 
compound (OCT) and HPLC grade acetonitrile, chloroform, isopropanol and methanol were 
obtained from Fischer Scientific (Hemel Hempstead, UK). Vectashield mounting medium with 
4',6-diamidino-2-phenylindole (DAPI) obtained from Vector Laboratories Ltd (Peterborough, 
UK).  MilliQ ultrapure water (18 mΩ cm-1) was used for all aqueous solutions.  All materials 
were used as supplied without modification. 
 
Preparation of solutions. PBS was prepared in-house and was adjusted to pH 7.4 using 0.1M 
solution NaOH.8  Ion-pair buffer was prepared using sodium hexane-1-sulfonate monohydrate 
adjusted to pH 3.0 using glacial acetic acid.9 
 
HPLC analysis. HPLC analysis was conducted using a manual injection HPLC system 
(Perkin Elmer Inc, UK) comprising of  Flexar UV-Vis detector (FXUVDET), Flexar binary 
pump (FXBPump2), Flexar solvent manager (3CH Degasser), Ascentis C18 column, 150 x 4.6 
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mm, 5μm, (part number: 581324-U) and data acquisition software (Chromera, version 
3.2.0.4847). 
Analysis of riboflavin was achieved with a run time of 4 minutes using the method adapted 
from Anyakora et al.9 Isocratic conditions were used at ambient temperature with the mobile 
phase comprising of 40% methanol and 60% ion-pair buffer, flow rate 1.2 mL min-1, 10 ȝL 
injection volume,  UV detector at β67 nm corresponding to riboflavin absorption Ȝmax, a retention 
time of 2.4 minutes. Quantitation was achieved by reference to a calibration curve produced from 
riboflavin standards at concentrations ranging from 0.00001 to 0.01 mg mL-1 (r2 = 0.9996).  
HPLC method for cholesterol analysis was adapted from the protocols reported by Hoving10 
and Osman and Yap.11 Isocratic conditions were used at ambient temperature with the mobile 
phase comprising of 60% acetonitrile and 40% isopropanol at 1 mL min-1 flow rate, injection 
volume 10 ȝL, with 10 minutes runtime, UV detector at 210 nm.  Solutions of cholesterol in 
isopropanol were prepared at 0.005, 0.05 and 0.5 mg mL-1, and used to identify its retention time 
at 7.9 minutes. 
 
Preparation of animal tissues. Bovine eyes were provided by P C Turners abattoirs 
(Farnborough, UK) and stored on ice during transport.  The eyes were carefully handled and 
used whole or cornea dissected depending on the experiment.  Dissection took place within four 
hours of slaughter.  Using a sharp blade, the cornea with 2-3 mm of sclera attached was carefully 
removed, quickly rinsed with PBS and wrapped in cling film to prevent dehydration.   Fresh 
tissues were stored at 4°C in a refrigerator and used within 48 hours prior to experiments (fresh 
cornea), or were stored at -18°C until use (cryopreserved cornea).   
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Cornea sections from experiments were prepared by setting the cornea segment in OCT, quick 
freezing on dry ice and subsequent microtome sectioning.  Specimens were prepared for 
microscopy using a microtome (Bright, model 5040) within a cryostat (Bright, model OTF).  
Sections were cut at 7 ȝm,  placed in groups of four on 75mm x 25mm glass slides, dried gently 
using a hot air blower on low power for ten minutes from a distance of 50 cm.  The specimens 
were stained using Vectashield with DAPI mounting medium and a glass coverslip placed over 
the specimens.  All cornea sections were examined within 48 hours of preparation using an 
AXIOCAM MRm1.3 MP digital camera attached to a Zeiss AXIO Imager A1 fluorescent 
microscope, using AXIO Vs 40 V.4.8.2.0 software (Zeiss, Oberkochen, Germany).  A 10 x 
magnification eyepiece together with a 5 x magnification objective lens was employed, and a 
light filter for DAPI fluorescence was selected. 
 
Effect of cyclodextrins on the solubility of riboflavin.  Solutions of α-, Ȗ- and hydroxypropyl-
ȕ-cyclodextrins in ultrapure water were prepared at 10, 20, 30, 50 and 100 mg mL-1.  ȕ-
cyclodextrin is known to have lower aqueous solubility (18.5 mg mL-1) at room temperature, 
increasing with higher temperature,12-14 therefore solutions were prepared at 10, 20 and 30 mg 
mL-1. ȕ-cyclodextrin was heated to 60°C to dissolve, all other solutions were stirred at 35°C until 
dissolved.  ȕ-cyclodextrin slowly crystallizes from solution upon storing at room temperature, 
however this re-dissolved quickly when heated to 60°C, then cooled to physiological 
temperature.  Cyclodextrin solutions were saturated with riboflavin by adding an excess at 1 mg 
mL-1 and stirring overnight.  Riboflavin saturated water was prepared as a control. Our 
preliminary observations have shown that riboflavin is photodegradable in solution (data not 
shown); this is also in agreement with the data reported by Terekhova et al.15 Therefore in all 
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experiments riboflavin preparations were wrapped in aluminum foil to prevent its photo-
degradation.  HPLC analysis was carried out on the riboflavin saturated solutions to determine 
the effect of cyclodextrin on its solubility after passing them through 0.2 μm syringe filters. 
Phase-solubility analysis was used to determine association constants the complexation.16 
 
Corneal permeability.  The effect of cyclodextrin on corneal permeability of riboflavin was 
studied in vitro using Franz diffusion cells.  Solutions of α-, ȕ-, Ȗ- and hydroxypropyl-ȕ-
cyclodextrins in ultrapure water were prepared at 30 mg mL-1 which was subsequently dosed 
with riboflavin at 0.08 mg mL-1; an aqueous drug solution at the same concentration was also 
prepared as a control. Bovine corneas were mounted between  donor and receiver compartments 
of standard Franz diffusion cells, epithelium side facing  uppermost.  The receiver compartment 
was filled with pre-warmed PBS (16.5 mL), ensuring no air bubbles were trapped under the 
membrane. Experiments were conducted in a water bath, stirred at 34°C ± 1°C to mimic  
physiological temperature at the corneal surface.17,18 1 mL of riboflavin in water or in 
cyclodextrin solution was added to the donor compartment, and then sealed with cling film to 
prevent evaporation.  All apparatus was entirely covered with aluminum foil to exclude light.  
HPLC analysis was carried out at the time of sampling to avoid drug degradation; sink 
conditions were not employed because low volume (0.2 mL) aliquots were taken every 30 
minutes for 180 minutes and this did not significantly reduce the cell volume.  Experiments were 
carried out in triplicate using different corneas for each repeat. 
 
Corneal integrity.  The effect of cyclodextrin on corneal integrity was investigated using 
fresh, whole bovine eyes each placed in individual 150 mL beakers, cornea facing uppermost. A 
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Franz diffusion cell donor compartment was placed on the cornea and held in place using cling 
film ensuring a good seal at the cornea surface; the beakers were placed in a water bath at 37°C, 
and allowed to equilibrate for 60 minutes after which 1 mL of cyclodextrin solution was added to 
the donor compartment by syringe (experimental set up is shown in Figure 1S in Supplementary 
Information).  Corneas were exposed to cyclodextrin solutions for 15, 45 and 75 minutes.  The 
rationale for using whole eyes during this experiment was to avoid swelling of the stroma that is 
observed when using dissected cornea in Franz diffusion cells.  Immediately after  exposure time 
had elapsed, the experimental set up was disassembled and  cornea dissected, mounted in OCT 
on dry ice, and examined using microscopy.  
A further experiment was designed to investigate the ability of cyclodextrin to extract 
cholesterol from corneal epithelia.  Corneas of whole bovine eyes were exposed to α, ȕ, Ȗ and 
HP-ȕ-cyclodextrin solution (30 mg mL-1) for 90 minutes, then the cyclodextrin solution was 
carefully recovered using a 1 mL syringe without a needle; 5 eyes were used for each 
cyclodextrin and  recovered doses were combined giving ~5 mL of cornea exposed solution for 
each cyclodextrin.  These were placed in glass vials to which 10 mL of chloroform was added, 
capped and shaken, then left to stand at room temperature for 1 hour, 50 mL ultrapure water was 
added. The mixture was filtered, allowed to settle into aqueous (upper) and organic (lower) 
phases, and then separated.  The solvent was allowed to evaporate off from the organic phase, 
and 0.5 mL of isopropanol was added to dissolve the residue and analyzed by HPLC. 
 
 
Results and discussion 
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Effect of cyclodextrins on solubility of riboflavin. Cyclodextrins are toroid shaped 
oligosaccharides with hydrophilic external surfaces and a lipophilic internal cavity. They are able 
to form guest-host inclusion complexes with hydrophobic compounds rendering them more 
soluble.12,19 Studies have shown that pre-treatment using cyclodextrin solutions can enhance 
corneal permeability of some drugs such as pilocarpine.20 Sultana et al reported their use in 
formulations containing corticosteroids, chloramphenicol, diclofenac and cyclosporine.21 Roy et 
al22 and Terekhova et al15 have demonstrated that riboflavin can form complexes with 
cyclodextrins; however, their studies were limited to the dynamics of complexation using α- and 
ȕ-cyclodextrins. To the best of our knowledge no study has been reported on the effects of 
cyclodextrins on corneal permeability of riboflavin.  
Our experiments have shown that riboflavin has relatively low aqueous solubility at ~0.079 mg 
mL-1 (0.209 mM L-1) in deionized water and it is in agreement with the literature.23,24  Drug 
permeability through biological membranes is typically expected to increase when higher 
concentration formulations are employed, therefore cyclodextrins ability to enhance the aqueous 
solubility of riboflavin was investigated.  It was found that α-cyclodextrin at 100 mg mL-1 and ȕ-
cyclodextrin 20 and 30 mg mL-1 offered a significant (p < 0.05) enhancement in the aqueous 
solubility of riboflavin, but Ȗ- and hydroxypropyl-ȕ-cyclodextrin failed to enhance drug 
solubility to any significant level (p > 0.05), compared with its solubility in water. 
The cavity of cyclodextrin determines which molecules are able to form inclusion complexes. 
When the cavity is small, as with α-cyclodextrin (4.7 – 5.3 Å), many drug molecules will be too 
large to fit and will not be able to form inclusion complexes. When the cavity is too large drug 
molecules may be bound only loosely.12  ȕ-cyclodextrin proves suitable for many pharmaceutical 
applications, with a cavity size of 6.0 – 6.5 Å that can accommodate a wide range of drugs.13  
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The size of  riboflavin molecule determined using Jmol25 software was found to be 10 x 12 Å 
(Figure 2). This is too large to completely fit within any cyclodextrin cavity; however, the 
aromatic ring with attached methyl groups would suitably accommodate within ȕ-cyclodextrin’s 
cavity and bind through weak hydrophobic effects. The cavity of α-cyclodextrin would be too 
small to accommodate the aromatic ring of riboflavin although partial complexation via the 
methyl groups could occur.  Involvement of  other parts of the riboflavin molecule, such as the 
ribitol chain and pyrimidine ring could be ruled out as these are highly polar, hydrophilic and 
would be unlikely to participate in the formation of an inclusion complex. The fit would be too 
loose in the case of Ȗ-cyclodextrin.  
 
 
Figure 2.   Computer generated image of riboflavin showing dimensions. 
 
Complexation of riboflavin with cyclodextrins was determined by phase-solubility analysis, 
Figure 3, from which the association constants  (KCD:RF) were determined using the methods 
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reported Jarho et al,26 Table 1.  Size considerations and association constants give reasonable 
explanation for the superior performance of -cyclodextrin in solubilization of riboflavin.  
 
 
 
Figure 3.   Phase solubility diagrams of α, β, Ȗ and hydroxypropyl-β-cyclodextrin   
 
Table 1.   Riboflavin association constant and cyclodextrin enhanced solubility 
                compared to riboflavin in de-ionized water 
Cyclodextrin Riboflavin  Association constant Riboflavin solubility  
30 mg mL-1 mg mL-1 KCD:RF mol-1 enhancement % 
α-CD 0.081 4.32 3.2 
ȕ-CD 0.191 57.62 142.8 
Ȗ-CD 0.08 5.27 1.7 
HP-ȕ-CD 0.084 5.75 7.3 
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Corneal permeability of riboflavin.  Drug permeability studies often rely on the regular access 
to suitable biological tissues, and fresh material is not always available. Therefore 
cryopreservation offers a convenient means to store biological samples until needed. Human 
amniotic membrane is an example of material that can be cryopreserved until required.  It is used 
for wound protection, ocular surface reconstruction and drug delivery.27-30 Cryopreserved 
samples are also often employed in drug permeability studies; however, there is little known on 
the effect of cryopreservation on the barrier function of the cornea. 
In the present study we investigated the effect of cyclodextrins (30 mg mL-1) on the permeability 
of riboflavin (0.08 mg mL-1) through fresh and cryopreserved bovine cornea. The permeation of 
riboflavin from cyclodextrin-free formulation into the receiver solution is observed within ~75 
minutes in experiments with fresh bovine cornea, whilst this lag time reduced to ~40 minutes in 
the case of cryopreserved tissue (Figure 4). The existence of this lag time is related to the initial 
penetration of the drug into the cornea before it starts to permeate.  Levels of riboflavin in 
receiver solution recorded at 180 minutes of the diffusion experiment were 0.0054 ȝg mL-1 and 
0.0515 ȝg mL-1 for fresh and cryopreserved cornea, respectively.  
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Figure 4.  Cyclodextrin enhanced riboflavin permeability differences: (a) cryopreserved bovine 
cornea; (b) fresh bovine cornea.   *p < 0.05,   ***p < 0.001, paired t-test, n=3.  Note: different 
scales for the y axis. 
 
Comparing cyclodextrin enhanced permeability of riboflavin at 180 minutes it was found that β- 
and HP-ȕ-cyclodextrins significantly enhanced riboflavin permeability to 0.0159 ± 0.0010 ȝg 
mL-1 and 0.0094 ± 0.0016 ȝg mL-1 respectively for fresh cornea (p < 0.05), but α- and Ȗ-
cyclodextrin offered no significant improvement in drug permeation.  For  cryopreserved corneas 
ȕ-cyclodextrin significantly enhanced riboflavin permeability to 0.1132 ± 0.0143 ȝg mL-1 (p < 
0.001), whilst α-, Ȗ- and hydroxypropyl-ȕ-cyclodextrins offered no enhancement. 
Statistically significant differences (p < 0.001) were observed for riboflavin permeability 
between cryopreserved and fresh corneas. 
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Further interpretation was achieved by calculating steady-state flux and apparent permeability 
coefficients (Papp) from phase solubility diagrams comparing aqueous riboflavin solution and 
riboflavin/cyclodextrin solutions, Table 2.  Overall an order of magnitude increase in drug 
permeability through cryopreserved tissues was observed compared to fresh corneas. 
 
Table 2.  Steady-state flux and apparent permeability coefficient (Papp) of riboflavin through  
                bovine cornea in the presence and absence of cyclodextrin 
   
Fresh 
 
Cryopreserved 
   
Steady state flux 
 
Papp   cm s-1 
 
Steady state flux 
 
Papp   cm s-1 
Solution   ȝmol minute-1   Х 10-8   ȝmol minute-1   Х 10-8 
Riboflavin (0.08 mg mL-1) 
in;               
De-ionised water 
 
0.0002 
 
0.49 
 
0.0014 
 
8.57 
α-cyclodextrin (30 mg mL-1) 0.0003 
 
1.72 
 
0.0014 
 
10.1 
ȕ-cyclodextrin (30 mg mL-1) 0.0006 
 
2.69 
 
0.0024 
 
12.8 
Ȗ-cyclodextrin (30 mg mL-1) 0.0006 
 
0.42 
 
0.0011 
 
5.10 
HP-ȕ-cyclodextrin (30 mg 
mL-1) 0.0015   3.35   0.0011   6.34 
 
 
To provide a further insight into the effect on cryopreservation of bovine cornea on its 
permeability we have evaluated the integrity of corneal tissues using microscopy. Microscope 
slides were prepared using fresh, one week and six weeks cryopreserved bovine cornea (-18°C) 
to investigate any morphological differences between these tissues (Figure 5). It can be seen 
from the micrographs that epithelium of fresh cornea is intact and adhered to underlying stroma 
of fresh tissue.  In one week frozen cornea, integrity of epithelium showed signs of degradation 
and at six weeks, there was evidence of significant degradation to the epithelium.   
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Figure 5.   Micrographs of bovine cornea cross-sections: (a) Fresh cornea;  (b) one week 
cryopreserved cornea; (c) six weeks cryopreserved cornea. Scale bar = 100 μm. 
 
It appears that epithelium degradation increases with increased time when stored at -18°C and 
this is likely to be due to the formation of ice crystals developing in the cellular matrix, and 
possibly from  ‘freeze drying’ effect of stored tissue.  For all samples there was no visual 
evidence of degradation to the stroma, however, Fullwood and Meek31 and Yi-fei et al32 report 
structural changes in the stroma due to cryopreservation when investigated using synchrotron X-
ray diffraction techniques.  
Further microscopy experiments were conducted to establish the effect of cyclodextrins on the 
integrity of fresh bovine cornea.  Figure 6 compares images of fresh bovine cornea treated with 
30 mg mL-1 ȕ-cyclodextrin solution with control samples.  In each figure, images to the left are 
from unexposed regions of cornea, images to the right are from cyclodextrin solution exposed 
regions, with increasing exposure at 15, 45, 75 minutes.  Samples treated with ȕ-cyclodextrin 
show some epithelial disruption, which becomes more noticeable with longer exposure time. At 
15 minutes exposure we begin to see what looks like a loosening of the cell structure in the 
surface of the epithelium; at 45 minutes this phenomenon becomes more pronounced and at 75 
minutes the changes are apparent throughout the whole epithelial layer. 
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Micrographs for α-, Ȗ- and hydroxypropyl-ȕ-cyclodextrin exposed corneas are given in 
Supporting Information (Figures 2S, 3S and 4S) and they show a similar trend of increasing 
epithelium disruption with increasing exposure time to cyclodextrin solutions.  All images shown 
are representative examples, considerable variation was observed between samples of the same 
exposure time due to natural tissue variability.  
 
 
Figure 6.   Micrographs of bovine cornea exposed to 1 mL β-cyclodextrin (30 mg mL-1) (b, d 
and f) against non-exposed regions (a, c and e). Exposure time: 15 minutes (a and b), 45 minutes 
(c and d) and 75 minutes (e and f). Scale bar = 100 μm. 
 
Cyclodextrin-mediated cholesterol extraction.  Cellular membranes are known to consist of 
lipid bi-layers interspersed with cholesterol-rich lipid rafts, and corneal epithelial cells also 
consist of similar membranes. Cyclodextrins have previously been reported to extract cholesterol 
and other lipids from cell membranes. Zaidi et al investigated the effect of β-cyclodextrin on 
laboratory cultured human corneal cells in vitro and murine corneal tissue in vivo.33 They 
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demonstrated the disruption of lipid rafts and hypothesized that it is related to extraction of 
cholesterol from the plasma membrane of epithelial cells. Ohtani et al studied the influence of α-, 
ȕ- and Ȗ-cyclodextrins on human erythrocytes and demonstrated that ȕ-cyclodextrin extracted 
cholesterol from cell membranes.34    
To prove the extraction of cholesterol from bovine cornea under experimental conditions used 
in this work, cyclodextrin solutions that had been in contact with biological tissues together with 
positive and negative controls, were analyzed using HPLC. Figure 7 shows evidence of 
cholesterol extraction employing ȕ-cyclodextrin and hydroxypropyl-ȕ-cyclodextrin, no such 
evidence was seen for corneas exposed to water, α- and Ȗ-cyclodextrin.   
 
 
Figure 7.    HPLC traces from analysis of cyclodextrin mediated cholesterol extraction. 
Conclusions  
This study has shown that the solubility of riboflavin can be enhanced using α-cyclodextrin at 
100 mg mL-1 and β-cyclodextrin at 20 - 30 mg mL-1, thereby increasing its availability when 
used in ocular drug formulations.  Permeability of riboflavin through fresh bovine cornea has 
-1
0
1
2
3
4
5
6
7 7.5 8 8.5 9
A
bs
or
ba
n
ce
Retention time, minutes
?-CD, extract
HP-?-CD, 
extract
Water, negative
control
Cholesterol,
positive control
18 
 
been shown to improve in the presence of β- and hydroxypropyl-β-cyclodextrins; however, only 
β-cyclodextrin enhanced permeability through cryopreserved cornea.  The study has shown that 
there is an order of magnitude difference in riboflavin permeability between fresh and 
cryopreserved bovine corneas and the lag time reduced from ~75 minutes for fresh corneas to 
~40 minutes for cryopreserved materials. Microscopy has highlighted morphological differences 
between fresh and cryopreserved ocular tissue which should be taken into consideration when 
using cryopreserved corneas as permeability models. 
 Aqueous cyclodextrin solutions have been shown to disrupt the epithelium integrity at the 
cornea surface and might offer a means to render this lipophilic barrier less resistive to 
permeation of aqueous solubilized compounds.  Our study has shown that cyclodextrins have the 
ability to extract cholesterol and other lipids from ocular cellular membranes; this could provide 
an explanation for the observed epithelium disruption and enhancement to permeability. 
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Supporting information 
The supporting information provided here shows an experimental set up for corneal exposure 
to drug formulations using a ‘whole eye’ method (Figure 1S). 
 
Figure 1S   Schematic of a whole eye experimental set up developed during the course of this 
study, this method allows the cornea to be exposed to drugs without prior dissection. 
 
Micrographs of cornea cross-sections from cyclodextrin exposure experiments, Figure 2S 
shows micrographs from α-cyclodextrin experiments, Figure 3S from ?-cyclodextrinand Figure 
4S from hydroxypropyl-β-cyclodextrin.  Images to the left of the frame are non-exposed sections 
and images to the right are cyclodextrin exposed sections. Moving down the frame show images 
of progressively longer duration of exposure at 15, 45 and 75 minutes.   
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Figure 2S.Micrographs of bovine cornea exposed to α-cyclodextrin (30 mg ml-1). Images a and 
b, 15 minutes, c and d, 45 minutes, e and f, 75 minutes exposure. Images a, c and e from non-
exposed regions, b, d and f from cyclodextrin exposed regions. 
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Figure 3S   Micrograph of bovine cornea exposed to ?-cyclodextrin(30 mg mL-1). Images a and 
b, 15 minutes, c and d 45 minutes, e and f, 75 minutes exposure.  Images a, c and e from non-
exposed regions, b.d and f from cyclodextrin exposed regions. 
 
Figure 4S   Micrograph of bovine cornea exposed to hydroxypropyl-β-cylodextrin (30 mg mL-1). 
Images a and b, 15 minutes, c and d 45 minutes, e and f, 75 minutes exposure.  Images a, c and e 
from non-exposed regions, b.d and f from cyclodextrin exposed regions. 
 
 
